News About: Pharm. Industry
Wholesalers suffers low margin
Domestic pharmaceutical wholesalers have seen their thin margins unchanged in their dealings with multinational firms here and new financial cost system have negatively affected their bottom lines, according to market...
Yuhan signs license agreement for new hepatitis B treatment
Yuhan Corp. said Wednesday that the company has concluded an agreement with the U.S.-based Gilead Sciences Inc., under which Yuhan will have an exclusive right to market Viread (tenofovir disoproxil fumarate) for trea...
Dong-A signs DA-9701 export deals
Dong-A Pharmaceutical Co. said Wednesday that it has inked a memorandum of understanding with Pahang (Malaysia) and Landson (Indonesia) for its in-house developed DA-9701, a new prokinetic agent formulated with Pharbi...
Local company to roll out new premature ejaculation drug
Jinyang Pharmaceutical and CTC Bio have recently announced that they will carry out Phase 3 clinical trials for the development of premature ejaculation (PE) drug.
The results of Phase 2 study demonstrated the safe...
Foreign hyperlipemia drugs increase market share
Foreign-made hyperlipemia medicines showed sustained growth of the sector’s domestic sales in February, an industry report showed recently.
According to Shinhan Investment Corp., Pfizer’s Lipitor and AstraZeneca’s ...
Whanin to launch new natural drug preventing Alzheimer’s disease
Whanin Pharmaceutical says it has completed Phase III clinical trial for the natural extract INM-176 (Angelica gigas), an effective drug for the prevention and treatment of Alzheimer’s disease.
“If the natural drug...
EPS of pharmaceutical firms analyzed
The average earnings per share (EPS) of 29 pharmaceutical companies was 2,141 won last year, down 391 won from 2,532 won, according to Yakup Shinmoon web site (www.yakup.com).
EPS is the portion of a company's prof...
Prescription drug market share of leading domestic drug makers by 1.5% in February
The combined market share of Korea’s 10 leading drug manufacturers in prescription drugs market dropped to 1.5 percentage points in February, compared with the same month from the previous year, according to data rele...
Multinational companies want rewards for clinical trials in Korea
As Korea is rapidly emerging as a global hub of clinical trials for multinational pharmaceutical companies thanks to its excellent infrastructure for clinical research, the Korean Research based Pharmaceutical Industr...
Dong-A sales to achieve 216.4 billion won in first quarter
Dong-A Pharmaceutical’s first quarter sales will increase by 7.7 percent this year, while its operating profits for the period will also increase by 7.7 percent compared to the same period last year, according to Kim ...
